In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

11th Tumor Models Boston

Jul 12, 2023 - 07:00 AM - Jul 13, 04:00 PM
Hanson Wade Group
The Westin Boston Seaport District
425, Summer St

ZIP: 02210
Phone: +16174554188

Ticket Price: Free: USD 0.00

Over the last 12 months, we have seen many combination therapies enter Phase I and II trials with both successes and challenges, particularly in solid tumors. The FDA Modernization Act 2.0 passing has also steered biopharma away from animal models, empowering the preclinical and translational tumor models' space to continue innovating and decrease the translational gap into the clinic.

At the 11th Annual Tumor Models Boston Summit, you will gain practical insights into the latest updates through 25+ case studies across 2 dedicated tracks. Join us to learn from and meet pioneers in preclinical and translational targeted, combination oncology to advance your candidates to patients with optimized translatability, efficiency, and cost-effectiveness!

Tickets: https://go.evvnt.com/1642229-2?pid=1052
Brochure: https://go.evvnt.com/1642229-3?pid=1052

Speakers: Aaron Goldman, Instructor in Medicine, Harvard Medical School, Antje Margret Wenger, Head of Immuno Ocology, Bayer AG, Aundrietta Duncan, Director, Non-Clinical Development, Salarius Pharmaceuticals, Carlos Gil del Alcazar, Lab Head, Novartis, Charles Lin, Senior Vice President, Kronos Bio, Dina Polyak, Senior Scientist II, Arsenal Biosciences, Doug Palmer, Executive Director, Immuno-Oncology Translational Medicine, AstraZeneca, Emmett Schmidt, Vice President, Merck, Francesca Vena, Business Development Director, Imagen Therapeutics, Giovanni Marconi, MD Consultant, Haematolog, IRST, John Maher, Chief Scientific Officer, LeucidBio, Joshua Breunig, Associate Professor, Cedars-Sinai Medical Center, Katie Grausam, Postdoctoral Scientist, Cedars Sinai, Kim Aardalen, Director, Preclinical Pharmacology Oncology, Odyssey Therapeutics, Ludovic Bigot, Project Manager, Gustav Rousey, Marco Campisi, Postdoctoral Research Fellow, Dana-Farber Cancer Institute, Melinda Day, Associate Director Translational Clinical Development, Kronos Bio, Michael Boice, Vice President, Scientific Engagement, TD2 Precision Oncology, Monika Buczek, PhD, Director of Business Development, Business Development, Natalia Malkova, Director, In Vivo Pharmacology, Xilio Therapeutics, Rakesh Awasthi, Senior Principal Scientist, Oncology Clinical Pharmacology, Novartis, Sam Chatterjee, Translational Scientist, Cell Therapy, Takeda, Shanthi Ganesh, Director, Discovery Research Pre-Clinical Oncology, Discerna Pharmaceuticals, Shou-Ching Jaminet, Co-Founder and Vice President of Discovery Science, Anglex, Stephanie Casey Parks, Senior Scientist, Oncology and Inflammation, Amgen, Steve Anderson, Consultant, Precision Medicine and Oncology, Tessa DesRochers, Chief Scientific Officer, Kiyatec Inc, Yongxian Zhuang, Director, Cancer Pharmacology, Revolution Medicines

Event Categories
Keywords: oncology


Events Calendar

25 26 27 28 29 30 1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31 1 2 3 4 5

Event Location


VIP Life Time Subscription to our Newsletters!